Stay updated with breaking news from Precaution Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Get latest articles and stories on India at LatestLY. Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources. India News | Phase 2,3 Trial Data of India's First MRNA COVID Vaccine Submitted to DCGI.
Pune-based Gennova Biopharmaceuticals, India's first mRNA COVID vaccine
Pune-based Gennova Biopharmaceuticals has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity.
Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
The appeal from the Prime Minister came as Covid-19 vaccination for all beneficiaries in the 12-14 age group began from Wednesday (March 16, 2022) at all government Covid vaccination centres.